2026 ICD-10-CM Diagnosis Code M72.2Plantar fascial fibromatosis

ICD-10-CM CodesM00–M99M70-M79M72

ICD-10-CM M72.2
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

M72.2 is a billable ICD-10-CM diagnosis code for plantar fascial fibromatosis. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 557 through 558. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified connective tissue disease.

Code Identity

ICD-10-CM Code
M72.2
Billable Status
Yes — Valid for Submission
Code Describes
Plantar fascial fibromatosis
Short Description
Plantar fascial fibromatosis
Same as the full description in the CMS dataset.
Parent Code
Fibroblastic disorders

Code Classification

ChapterM00–M99Diseases of the musculoskeletal system and connective tissue
SectionM70-M79Other soft tissue disorders
CategoryM72Fibroblastic disorders
This CodeM72.2Plantar fascial fibromatosis

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Bilateral fibromatosis of plantar fascia of feet
  • Bilateral plantar fasciitis
  • Contracture of plantar fascia
  • Fibromatosis of plantar fascia of left foot
  • Fibromatosis of plantar fascia of right foot
  • Fibromatosis with contracture of plantar fascia
  • Plantar fascial fibromatosis
  • Plantar fasciitis
  • Plantar fasciitis of left foot
  • Plantar fasciitis of right foot
  • Traumatic plantar fasciitis

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Plantar fasciitis

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Contraction(s), contracture, contracted
      • fascia (lata) (postural)
        • plantar
    • Contraction(s), contracture, contracted
      • plantar fascia
    • Fasciitis
      • plantar
    • Fibromatosis
      • plantar (fascial)
    • Syndrome
      • plantar fascia

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR MUS025
Other specified connective tissue disease
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Foot Injuries and Disorders

Each of your feet has 26 bones, 33 joints, and more than 100 tendons, muscles, and ligaments. No wonder a lot of things can go wrong. Here are a few common problems:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert M72.2 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
728.71 Plantar fibromatosis
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About M72.2Overview

Is M72.2 (Fibroblastic disorders) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report plantar fascial fibromatosis on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does M72.2 group to?

When plantar fascial fibromatosis is the principal diagnosis on an inpatient stay, it groups to MS-DRG 557, 558, with relative weights from 0.8932 to 1.4869 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of M72.2?

Under the General Equivalence Mappings, plantar fascial fibromatosis converts to ICD-9-CM 728.71 (plantar fibromatosis). The mapping is a direct match.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.